NASDAQ: SRPT - Sarepta Therapeutics, Inc.

Yield per half year: -18.58%
Sector: Healthcare

Current price
124.79 $
Average price
138.87 $ +11.28%

Average analyst price
200 $ +60.27%
Price based on EPS
132.94 $ +6.53%
Discount price Net Income
83.67 $ -32.95%
6.67/10

Average analyst price

Fair price = 200 $
Current price = 124.79 $ (difference = +60.27%)

Idea Price forecast Changes Expiration date Analyst
More details 200 $ +75.21 $ (60.27%) 04.02.2025 Piper Sandler

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 132.94 $
Current price = 124.79 $ (difference = +6.53%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -193.1 $
Current price = 124.79 $ (difference = -254.74%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -1 068.96 $
Current price = 124.79 $ (difference = -956.61%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription